CureVac to 'plow forward' with Covid vaccine despite disappointing results - CNBC

CureVac to 'plow forward' with Covid vaccine despite disappointing results    CNBC CureVac, the latest experimental coronavirus va... thumbnail 1 summary
  1. CureVac to 'plow forward' with Covid vaccine despite disappointing results  CNBC
  2. CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result  The Washington Post
  3. UPDATE 1-CureVac COVID-19 vaccine records only 48% efficacy in final trial readout  Yahoo Finance
  4. CureVac Covid-19 Vaccine Is 48% Effective in Pivotal Study  The Wall Street Journal
  5. Final Trial Results Confirm Disappointment on CureVac Vaccine  The New York Times
  6. View Full Coverage on Google News


from Top stories - Google News https://ift.tt/3htCuJH

No comments

Post a Comment

Subscribe to: Post Comments (Atom)